Nullfication Date 10-Feb-2016: This case was submitted under an incorrect Initial Receipt Date and will be nullified. 
All information was transferred to a
new case, 2016AP006416, which has been submitted
Follow-up report 2015AP006687 received from GSK (US2015GSK019864) on 10-Apr-2015, with IRD of 29-Jan-
2015. Patients laboratory data and treatment medication was added; mothers history was updated and concomitant
medications were added. Narrative was updated accordingly.
Reference number 2015AP006687 is a spontaneous case received from a lawyer on 10-Feb-2015, pertaining to a 
male neonate patient (DOB:(b) (6) ), who experienced hydrocephalus, pneumonia, diarrhea with blood stools, 
ventriculomegaly, abdominal pain, asthma, vomiting following drug exposure during pregnancy to paroxetine 
hydrochloride.
No medical history was reported. The mothers history and concomitant conditions included depression, asthma, 
gastroenteritis, tocolysis, and sinus tachycardia, epigastric pain, cough and sore throat. Family history included 
heart disease. Concomitant medications included hydrophilic (isopropanol, paraffin, sodium, stearyl alcohol) 
ointment applied to affected area twice daily, Albuterol (salbutamol) inhaler taken four times a day, and oral 
Pseudoephedrine 60 mg tablets taken four times daily as required for unknown indications; oral Guaifenesin DM 
(dextromethorphan hydrobromide) 200/20 mg per 10 ml taken every four hours as required for cough, bulk 
compound (unspecified) one teaspoon every four hours as required for sore throat.
From 01-Jan-2000 to 31-Dec-2003, the patients mother took 20mg paroxetine hydrochloride tablets, (dosage and 
route of administration unknown) for depression. The patient was exposed to paroxetine transplacentally (FOETAL 
EXPOSURE DURING PREGNANCY). The patient was born on (b) (6)  On 02-Jan-2011, the patient 
experienced vomiting (VOMITING), diarrhea with blood in stool (BLOODY DIARRHEA) and abdominal pain 
(ABDOMINAL PAIN). On unknown dates, the patient was diagnosed with asthma (ASTHMA) and pneumonia 
(PNEUMONIA). On (b) (6)  the patients clinical history included hydrocephalus (HYDROCEPHALUS). The 
patient had mild ventriculomegaly (CEREBRAL VENTRICULOMEGALY) which may have been due to tonsillar 
ectopia. The patient underwent brain surgery and ventricular surgery.
Laboratory tests included: TEST: Weight: RESULT: 47.6 TEST: Temperature RESULT: 99 Fahrenheit TEST: SaO2
RESULT: 98 TEST: Pulse RESULT: 144 TEST: Respiratory rate RESULT: 28 TEST: General appearance 
RESULT: moderate and alert TEST: Functional/nutritional assessment RESULT: Lips, gums dry and pale. TEST: 
Abdomen/GU RESULT: Tenderness, guarding. 
The action taken with the drug was not applicable. At the time of the report, the outcome of the events was 
Print Time: 15-JUL-2016 02:45 PM If a field is blank, there is no data for that field Page 64 of 250
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
unknown. The patient was receiving Allegra (fexofenadine hydrochloride), Singulair (montelukast sodium), 
Vitamins, Pulmicort (budesonide) and Atrovent (ipratropium bromide).